cas 827-20-3|| where to buy 5-Fluoro-2-(trifluoromethyl)aniline

Product Name:5-Fluoro-2-(trifluoromethyl)aniline

IUPAC Name:5-fluoro-2-(trifluoromethyl)aniline

Packing Unit	Available Stock	Price($)
CM255193-5g	in stock	Ȥƴœ
CM255193-10g	in stock	ŸȤƐ
CM255193-25g	in stock	ƴŪœ

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 827-20-3 regularly via the above email.

Additional Notes

Verification code*

refresh

: CAS NO:827-20-3; Molecular Formula:C7H5F4N; Melting Point:-; Smiles Code:NC1=C(C=CC(F)=C1)C(F)(F)F; Density:

: Catalog Number:CM255193; Molecular Weight:179.12; Boiling Point:185.6°C at 760 mmHg; MDL No:MFCD06660353; Storage:Keep in dark place, inert atmosphere, store at 2-8°C.

: Benzenes; Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

: PF-06648671; The Journal of Medicinal Chemistry recently publishes an article titled, “Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer’s Disease”. Amyloid β-peptide (Aβ) accumulation is one of the key hallmarks of Alzheimer’s disease (AD). γ-secretase cleaves the amyloid precursor protein (APP) into pathologically relevant Aβs, and has been widely studied as a potential target for the treatment of AD.
Pfizer‘s PF-06648671 is a Gamma secretase modulator (GSM) targeting APP processing. It is found to have excellent central exposure in human and robust reduction of amyloidogenic forms (Aβ42) in cerebrospinal fluid (CSF).